Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Can Artificial Intelligence Advance Rare Disease Treatments?

SMi Group
Posted on: 19 Sep 17
Can Artificial Intelligence Advance Rare Disease Treatments?

The 7th annual Orphan Drug and Rare Disease conference will be taking place on 18 - 19 October, London, UK and is an event not be missed this year. We are once again proud to deliver another fantastic speaker line up and content-filled agenda that represents the whole orphan drug & rare disease landscape. The 2017 event will address the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases. 

There is only FOUR weeks left to register your attendance to hear from experts who are assessing potential market opportunities for orphan drugs and developing market access strategies in Europe to ensure patient access to therapies in development are commercially available.  

Through strategic keynote presentations, themed sessions and dedicated networking opportunities, attendees will have the chance to really tailor the event to the needs of their day-to-day roles.

This year's topical conference has attracted an international audience from France,
Germany, Italy, Netherlands, Switzerland, United Kingdom, USA and more!


4 Key Take-Aways from Orphan Drugs and Rare Diseases UK, will include:


1. Keynote sessions from Idorsia Pharmaceuticals Ltd, Vertex Pharmaceuticals and Summit Therapeutics assessing emerging treatment approaches to different rare diseases.

2. Progress your treatment with improving the efficacy and safety profile of biological therapeutics, identifying the decision matrix and developing the next generation gene therapy vectors by hearing from Selecta Biosciences, Sanofi and German Cancer Research Centre (DKFZ).

3. The value of orphan drug reimbursement and repurposing. Listen to hard hitting access & pricing talks with perspectives from the UK and Italy as well as industry experts from MPS Society, Alexion Pharma, Chiesi Farmaceutici S.p,A.

4. Exclusive Interviews from the industry. Find out what Cambridge Rare Disease Network, Birmingham Children's Hospital, Ataxia & University of Groningen ultimately hope to achieve in the orphan drug space.


Orphan Drugs and Rare Diseases 2017 is proudly sponsored by TCR Solutions.


Running alongside the conference will an exclusive pre-conference workshop held on Tuesday 17th October 2017.

WORKSHOP: Rare Diseases Challenges and Opportunities

Workshop Leaders: Larissa Kerecuk, Rare Disease Lead, Consultant Paediatric Nephrologist, Birmingham Children’s Hospital & Janet Tuberville-Greenlay, Roald Dahl; Rare Disease Transitition Sister, Birmingham Children’s Hospital


For sponsorship packages: Contact Alia Malick +44 (0) 207 827 6168 or e-mail

For media enquiries, contact Kyra Williams on +44 (0) 20 7827 6012 or email 


Orphan Drugs and Rare Diseases UK

18th – 19th October 2017

London, UK
Contact e-mail:
Contact tel: +44 (0) 207 827 6012


---- END ----

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at



For more information:

Editor's Details

Kyra Williams
SMi Group

Last updated on: 19/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.